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Background: The use of whole-genome sequencing in microbiology at a diagnostic level, although feasible, is still
limited by the expenses associated and by the complex bioinformatics pipelines in data analyses. We describe the
use of target enrichment-based next-generation sequencing for pneumococcal identification and serotyping as
applied to the polysaccharide 23 valent vaccine serotypes as an affordable alternative to whole genome sequencing.
Results: Correct identification of Streptococcus pneumoniae and prediction of common vaccine serotypes: 12 to
serotype level and the rest to serogroup levels were achieved for all serotypes with >500 reads mapped against
serotypes sequences. A proportion-based criterion also enabled the identification of two serotypes present in the same
sample, thus indicating the possibility of using this method in detecting co-colonizing serotypes. The results obtained
were comparable to or an improvement on the currently existing molecular serotyping methods for S. pneumoniae
in relation to the polysaccharide vaccine serotypes.
Conclusion: We propose that this method has the potential to become an affordable and adaptable alternative to
whole-genome sequencing for pneumococcal identification and serotyping.
Keywords: Next generation sequencing (NGS), Streptococcus pneumoniae, SerotypingBackground
Identification and capsular serotyping of S. pneumoniae
(pneumococcus) remains the cornerstone both for the
diagnosis and surveillance of pneumococcal disease and
carriage in the presence of extended spectrum pneumo-
coccal conjugate vaccination. Currently available biochem-
ical, serological and molecular methods are restricted by
their throughput, turnaround time and limitations in mul-
tiplexing for multiple serotype detection [1,2].
Next Generation Sequencing (NGS) is a technique
with the potential to fill this gap. Whole Genome Se-
quencing (WGS) on NGS platforms has been used for
serotype prediction and for studying serotype changes in* Correspondence: margaretip@cuhk.edu.hk
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article, unless otherwise stated.response to clinical interventions at research level [3,4].
In the diagnostic laboratory, WGS has been used to in-
vestigate potential outbreaks of drug-resistant pathogens
[5]. However, the routine use of WGS with bench-top
NGS remains limited by complex bioinformatics pipe-
lines, computational capacities, relatively lower through-
put per run without sample pooling, longer preparation
times, and substantial costs.
Use of target enrichment followed by NGS has gained
a wider use in cancer studies and the mutation analyses
associated with congenital diseases [6,7]. The use of
indexed sample preparation methods and pooling mul-
tiple samples lower the costs further. The combined use
of target enrichment and sample pooling is gaining
popularity as an option to sequence only the targets of
interest at a higher depth of coverage enabling a more
cost-effective use of sequencing reads; however, thisCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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biology. While the relatively smaller genome sizes in
microbiology make the application of WGS attractive,
adequate depth of sequences for interpretation may not
be readily achievable. Target enrichment will enable a
more cost-effective use of NGS in microbiology and over-
come the issue of low copy numbers in the regions of inter-
est. In this study, we explored a methodology based on
target enrichment coupled with tagged sample pooling
for the identification and serotyping of S. pneumoniae
by using NGS. Criteria for the correct assignment of
23-valent polysaccharide vaccine (PPSV23) serotypes
in relation to the total number of mapped reads per
sample and the proportion of reads aligned to reference
serotype sequences were also evaluated.
Methods
Bacterial isolates and DNA isolation
Twenty-four representative strains of S. pneumoniae of
the PPSV 23 serotypes and serotype 6A, along with
NCTC11189 Streptococcus sp. viridans type, obtained
from the culture collection at the Department of Micro-
biology, The Chinese University of Hong Kong were
used for the study. Isolates were grown overnight on
blood agar plates. DNA was extracted by boil lysis, and
the supernatant after centrifugation at 6,010 g for five
minutes was used as the template. DNA quality and
quantity of the neat and diluted samples were measured
by the nanodrop method. In addition, multiple serotypes
in varying proportions were also examined. Serotypes
19F and 3 were mixed in the proportion of 1:1, 1:10,
1:50, and 1:100 (1 = 75 ng/μl) to assess the feasibility of
multiple serotype detection. DNA from NCTC11189
Streptococcus sp. viridans type was combined with that
of serotype 19F at the proportions of 1:1, 1:10, 1:50, and
1:100 (1 = 75 ng/μl) to assess the feasibility of differenti-
ating S. pneumoniae from members of the viridans
group mimicking the nasopharyngeal niche.
Targeted enrichment of serotype specific regions and
sample pooling
A multiplex PCR using 23 previously described primer
pairs [8], capable of amplifying the capsular genes of the
polysaccharide vaccine serotypes (PPSV 23) and 17 closely
related types (PCR 1), was used for target enrichment.
An 18-bp nucleotide (nt) adaptor (TCTATTGGGCTAT
GTCAC) was incorporated to the 5’ end of each of the
primers. The PCR-amplified fragments ranged from
259 to 413 bp in length.
A second multiplex PCR in addition to the abovemen-
tioned 23 primer pairs incorporated a pair of consensus
primers (For- ATCGAACTCTTRCGYAATCTA and Rev-
TCAAACTTRTCTTTTGGATAAGARC) targeting a se-
quence signature in the lytA gene capable of differentiatingpneumococcus from the viridans group of streptococci
(PCR 2).
Thermodynamic properties of the resultant primer
adaptor combinations were evaluated by using the
Oligoanalyzer 3.1 software (http://sg.idtdna.com/analyzer/
applications/oligoanalyzer/). Eight 5-nt unique indexes
were selected from the ready-made index sequences
available at http://cloud.github.com/downloads/faircloth-
lab/edittag/edit_metric_tags.txt [9]. One of these 5-nt
indexes was attached to amplicons from each sample
by way of a modified step-out PCR (MSO-PCR), so that
the samples could be pooled prior to the library prepar-
ation [10]. The primer used for MSO-PCR had the
same sequence as the 18-nt adaptor with unique 5-nt
indexes at the 5’ end.
PCR 1 and 2 were performed by using the Platinum ®
multiplex PCR kit (ABI by Life Technologies) with 1 μl
of DNA extract as a template in a total reaction volume
of 10 μl. The MSO-PCR had a total volume of 50 μl with
4 μl of PCR1 or PCR2 amplicons as templates and used
Acti Taq DNA polymerase (Roche Diagnostics) for amp-
lification. Thermocycling parameters were in accordance
with the respective manufacturers’ instructions with
annealing temperatures of 60°C and 53°C for 30- and
15-cycles, respectively.
Sequencing and sequence analysis
PCR amplicons were purified by using a QIAquick PCR
product purification kit (Qiagen) and quantified by using
Qubit (Life Technologies). Eight samples tagged with
unique indexes were pooled together at equal quantities
to create a single sample for library preparation. Library
preparation was performed by using TruSeq DNA li-
brary preparation kit V2 (Illumina) without fragmenta-
tion. Sequencing was performed on a Miseq bench-top
sequencer (Illumina) with 2 × 150 bp methodology.
Paired-end sequencing data from the Miseq reporter
software was further analyzed off instrument. Quality
filtering of the paired end data, de-multiplexing and
trimming was performed by using a FASTX toolkit
(http://hannonlab.cshl.edu/fastx_toolkit/) prior to map-
ping against reference sequences using Bowtie 2 [11].
The reference amplicon sequences for data alignment
were generated from accession numbers cited by Kong
et al. [8] for serotype-specific capsular gene sequences
and [Genebank: AJ419979 and Genebank: AJ244307] for
the atypical and typical pneumococcal lytA gene se-
quences, respectively.
Data analysis
The experiments with multiple serotypes were designed
to establish cut-off limits that would enable the identifi-
cation of one or more serotypes from a sweep of col-
onies while excluding the possibility of false positive
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percentage of reads assigned to each serotype out of the
total number of mapped reads per given sample was
calculated. The aim of PCR 2 that incorporated the lytA
primers was to establish cut-off limits to identify
pneumococci from previously unidentified α-haemolytic
streptococci and to assign predicted serotypes. The per-
centage of reads assigned to the typical or atypical lytA
genes out of the total mapped reads per sample and the
percentage of the reads assigned to each serotype out of
the total reads mapped against serotype sequences for the
given sample were calculated. The percentages of correct
serotype identification by using various criteria, including
the proportion of mapped reads and a defined minimum
number of total mapped reads, were examined.
Results and discussion
The total numbers of mapped reads in the samples with
a single serotype in the two reactions (PCR 1 and PCR
2) ranged from 169 to 4,987, with a median of 2,162
(IQR – 1,059, 3,691) reads, and 128 to 5,238, with a me-
dian of 1,658 (IQR – 807, 2,550) reads, respectively.
Considering all samples, the mean percentage reads
assigned to the correct serotype, per sample were 80.5%
(95% CI 72.0–89.0%) and 80.7% (95% CI 72.9–88.5%) in
the two PCR reactions, respectively. All serotypes but
one was correctly assigned when the percentage reads
matched to a single serotype exceeded 70% of all the
reads in the sample.
The percentages of correctly identified pneumococcal
serotypes based on various cut-off limits are listed in
Table 1. The first criterion for serotype allocation was
defined by the presence of >15% reads out of total reads
mapped against serotype sequences per sample. The per-
centages of correct serotype identification based on this
were 87.5% and 91.7% for PCR 1 and PCR 2, respect-
ively. The cut-off of >15% reads was calculated based on
the experimental evaluation of multiple serotypes (please
refer to paragraph 3 of Results and Discussion). The per-
centage of correct identification increased when more
stringent criteria were added in defining the cut-off. The
percentage of correctly serotyped isolates reached 100%
when only the samples with >500 reads mapped were
considered for serotype allocation. The results interpret-
ation for individual samples based on each of the three
criteria; >15% mapped reads (criterion 1), addition of >200
(criterion 2), or >500 (criterion 3) reads mapped against
the serotype sequences, are listed in Tables 2 and 3. Con-
sidering only criterion 1, in all five instances where sero-
types were incorrectly assigned, the total number of reads
mapped to the serotype sequences was <500. In PCR 1,
both samples with aberrant results had a total number of
mapped reads <200. For PCR 2, the correct identification
of a single serotype was possible in 21/24 (87.5%) of allsamples, 21/23 (91.3%) of samples with >200 reads, and
19/19 (100%) of samples >500 reads (Table 1). Thus, a
minimum number of reads mapped against serotype
sequences of >500 was considered as the criterion to
filter samples suitable for serotype allocation.
Table 4 shows the results of individual samples con-
taining two bacterial isolates tested for pneumococcal
identifications and/or serotype assignment. These results
of mixed serotypes were used to establish a minimum
percentage of reads as a cut-off for allocating serotypes,
and it enabled the identification of a second serotype.
The numbers of reads mapped against a given serotype
was not proportional to the original ratio of input DNA.
The total number of reads mapped against serotype 3
was in general lower than that of serotype 19F. The
mean proportion of reads mapped against serotype 3
was 18.4% (95% CI 16.0–20.8%) for PCR 1 (Table 4a)
and 18.2% (95% CI 15.6–20.8%) for PCR2 (Table 4b). A
cut-off of 15% based on the lower limit of total reads
mapped to particular serotype sequence, was used for
the assignment of a serotype. Accordingly, the result
would not be analyzed where the cut-off or coverage
threshold is not achieved [12]. Thus, we propose that
samples with >500 reads assigned to serotypes should be
considered for further serotype allocation and any sero-
type with >15% of the reads assigned should be consid-
ered as present within the sample. Applying both
criteria, 22 samples tested in PCR 1 and 19 samples in
PCR 2 were eligible for further analysis, and all these
samples were allocated serotypes correctly.
PCR 2 enabled the confirmation of pneumococcal
identification as well as the detection of the presence of a
viridans group of streptococci. Although the proportions
of the viridans group of streptococci and S. pneumoniae
were not quantifiable, it is possible to apply this method
to identify and serotype pneumococci from non-purified
primary cultures of α-haemolytic colonies.
The inability of the method to quantify the proportion
of serotypes or bacterial species within a sample could
be due to amplification bias in the PCR efficiency of the
primers and the differences in the target sequences.
However, a second serotype could still be qualitatively
identified.
The method used for quantification of DNA prior to
pooling the samples could be improved in terms of spe-
cificity by using a fluorescence based quantification
method and this may help to improve the results per-
taining to quantified identification. However, as the
measurement of DNA quality excluded possible protein
contamination and as the outcome was measured in a
qualitative manner instead of a quantitative manner, the
impact on the final results was negligible.
The pooling of samples with the addition of unique
nucleotide tags helped us to reduce the associated cost.
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1,951 (1,178–2,633) 87.1% (85.1–89.1%) 4.8% (2.3–7.3%) 19 100%
*Criteria for serotype allocation. Each category fulfilled the minimum criterion of >15% reads out of total reads assigned to the sample.
**Criterion of >15% reads out of total reads mapped assigned to the sample.
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positive identification of a second serotype due to
chimeric amplicon generation. Thus, to achieve a bal-
ance between detecting co-colonization and sample
pooling the cut-off for defining serotypes needs to be
fine-tuned for the given number of samples pooled and
it could therefore be considered as a limitation of the
method. Where the presence of a second serotype is a
possibility, the cut-off determination needs to consider
the possibility of including a false positive second sero-
type with a lower threshold and the false negative exclu-
sion of a minor serotype with a higher cut-off limit.
If the method is to be applied to identified pneumo-
coccal isolates where a single serotype is expected, the
serotype with the highest proportion of reads mapped
would be the only one found in the given sample. The
use of PCR 1 for target enrichment is sufficient when
the objective would be to identify the serotype of an iden-
tified pneumococcal isolate. The use of PCR 2 for target
enrichment is recommended when the template is DNA
from primary cultures or patient samples; as it identifies
the presence of pneumococci by the characteristic lytA se-
quences. This would enable the identification of samples
containing serotypes not included in the current PCR
and samples with abnormal non-pneumococcal isolates
harboring capsular sequences.
The protocol could potentially be extended to include
more serotypes and direct detection from clinical sam-
ples. The validation process could be improved with the
evaluation of the performance of different indexes and
the establishment of the maximum plexity achievable for
sample pooling. The whole process currently takes about
50 hours to complete; however, the method is amenable
to automation and the recently released Truseq Nano(Illumina/USA) commercial test has potential to reduce
the time required. Even with the current turn-around
time, this protocol is appropriate where a larger number
of samples are to be tested or if applied to direct sample
testing. The analysis process could be further simplified
by using the Custom Amplicon Workflow of Miseq re-
porter with alternative amplicon manifest created where
the in-house index-adaptor-primer sequences could sub-
stitute the upstream and downstream probe sequences
and a pseudo-genome created by all possible amplicon-
adaptor-index combinations could be used instead of the
reference genome.
As proof of concept, we demonstrated that target
enrichment-based NGS could be applied with similar re-
sults to the conventional molecular serotyping methods.
The serotype resolution for the PPSV 23 capsular types
from this method is similar to that of the recently rec-
ommended triplex RT-PCR method by CDC, Atlanta,
USA (http://www.cdc.gov/ncidod/biotech/strep/pcr.htm,
accessed on 01/06/2013). However the latter method
does not include serotypes 10A/F and 15B/C, and it re-
quires seven sequential PCRs. A sequetyping method
described by Leung et al. using a pair of consensus
primers, although is simpler in terms of the number of
primers used, does not achieve the same serotype group-
ing pattern as the one in the current protocol; further-
more, the success rate for samples of PPSV 23 serotypes
was lower at 86% [13]. All molecular methods, including
the current method, have the drawback of not being able
to differentiate some very closely related serotypes.
A number of comparable molecular methodologies
with the capability of detecting colonization of multiple
serotypes have recently been described [14-17]. Direct
clinical samples and the sweep of colonies from primary
Table 2 Detailed results of samples with a single serotype for serotype assignment










Criterion 1* Criterion 2** Criterion 3***
1 1 4,711 91.9 3.0 1 1 1
2 2 2,245 76.8 8.9 2 2 2
3 3 160 0 75.0 Wrong allocation
of serotype
Insufficient reads Insufficient reads
4 4 4,985 77.2 10.3 4 4 4
5 5 915 96.1 1.3 5 5 5
6 6B 2,213 96.8 1.0 6 6 6
7 6A 1,241 91.8 3.9 6 6 6
8 7F 222 81.5 6.3 7A/F 7A/F Insufficient reads
9 8 2,955 77.4 3.985 8 8 8
10 9V 4,823 75.5 14.1 9A/V 9A/V 9A/V
11 9N 4,987 88.7 3.0 9N/L 9N/L 9N/L
12 10A 4,257 81.4 6.9 10A/B 10A/B 10A/B
13 11D 1,703 84.9 5.9 11A/D 11A/D 11A/D
14 12F 5,625 94.7 1.9 12/44/46 12/44/46 12/44/46
15 14 2,110 88.3 3.1 14 14 14
16 15B 998 84.9 3.1 15B/C 15B/C 15B/C
17 17F 1,357 72.7 7.3 17F 17F 17F
18 18C 2,418 84.5 3.9 18 18 18
19 19A 3,124 82.0 7.7 19F 19F 19F
20 19F 2,864 87.7 4.9 19A 19A 19A
21 20 169 36.7 27.2 Serotypes 20 and
incorrect identification
of serotype 23F
Insufficient reads Insufficient reads
22 22F 1,948 92.8 3.7 22F/A 22F/A 22F/A
23 23F 1,877 95.1 2.6 23F 23F 23F
24 33F 625 94.4 2.4 33F/A/37 33F/A/37 33F/A/37
*Criterion 1: Any serotype with >15% sequence reads mapped assigned to the sample.
**Criterion 2: Samples with >200 reads considered for further typing AND fulfilled criterion 1.
***Criterion 3: Samples with >500 reads considered for further typing AND fulfilled criterion 1.
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methods. The sequential application of multiplex PCR
has been shown to detect multiple serotypes from naso-
pharyngeal secretions [14]. The currently widely used
CDC-recommended multiplex PCR is capable of identi-
fying 40 different sero-identities by eight multiplexes
while in the current method, a single PCR is capable of
enriching 23 polysaccharide capsular vaccine serotypes,
at least to related serogroups in a single reaction. There
is potential to expand the number of sero-identities in
the current method because the resolution is not limited
by the need for bands with detectable differences in
lengths. Microarray-based serotyping methods have been
used successfully to identify and type pneumococcal
serotypes [15-17]. However, microarray technology remains
expensive and it needs complex interpretations whereasthe bench-top NGS technology is becoming more user-
friendly [1]. PCR followed by capillary electrophoresis and
PCR followed by ionization mass spectrometry with the
capability of detecting multiple colonization, have also been
described [18,19]. However, NGS with its competitive
market is becoming more affordable and this is the first
instance to the best of our knowledge that target en-
richment coupled to NGS has been used to develop an
assay to identify and serotype S. pneumoniae.
The routine use of WGS in a microbiology laboratory
using the same platform has been evaluated recently
[20]. However, the number of samples to be pooled to-
gether is limited. Our results demonstrate that target
enrichment-based NGS could be used for the identifica-
tion and sequence-based serotype prediction of pneumo-
coccus. Development of proprietary chemistry-based
Table 3 Detailed results of samples with a single serotype for pneumococcal identification and serotype assignment













No of reads mapped for
viridans streptococci
(atypical lytA)
Criterion 1* Criterion 2** Criterion 3***
25 1 776 81.2 7.2 1 1 1 2,073 1
26 2 271 32.5 23.6 2 and incorrect 2 and incorrect Insufficient reads 4,123 0
ID of serotype 6 ID of serotype 6
27 3 1,127 78.9 8.8 3 3 3 4,646 0
28 4 416 39.2 31.3 4 and incorrect 4 and incorrect Insufficient reads 4,595 0
ID of serotype 1 ID of serotype 1
29 5 1,181 92.6 5.0 5 5 5 1,048 0
30 6B 2,501 97.4 1.3 6 6 6 1,294 0
31 6A 898 92.7 3.0 6 6 6 490 0
32 7F 360 89.2 5.0 7A/F 7A/F Insufficient reads 292 0
33 8 1,868 74.4 6.5 8 8 8 7,396 0
34 9V 2,095 83.2 4.5 9A/V 9A/V 9A/V 2,992 0
35 9N 5,238 91.7 2.5 9N/L 9N/L 9N/L 5,934 0
36 10A 4,341 82.0 7.8 10A/B 10A/B 10A/B 14,623 0
37 11D 1,951 85.3 7.0 11A/D 11A/D 11A/D 4,844 0
38 12F 5,224 92.6 1.7 12/44/46 12/44/46 12/44/46 5,881 0
39 14 1,968 88.2 3.6 14 14 14 4,624 0
40 15B 986 89.6 3.8 15B/C 15B/C 15B/C 1,184 0
41 17F 1,178 71.7 7.1 17F 17F 17F 5,387 0
42 18C 2,699 97.0 0.8 18 18 18 4,502 0
43 19A 2,644 82.2 7.7 19F 19F 19F 3,079 0
44 19F 2,598 87.1 5.7 19A 19A 19A 5,570 0
45 20 128 28.9 26.6 20 and incorrect Insufficient reads Insufficient reads 1,946 0
ID of serotype 23F
46 22F 1,683 92.5 4.2 22F/A 22F/A 22F/A 2,107 0
47 23F 1,633 94.2 2.1 23F 23F 23F 1,404 0
48 33F 475 93.5 2.1 33F/A/37 33F/A/37 Insufficient reads 496 0
^ Denominator - total number of reads mapped against serotype/group specific sequences.
*Criterion 1: Any serotype with >15% sequence reads mapped assigned to the sample.
**Criterion 2: Samples with >200 reads considered for further typing AND fulfilled criterion 1.















































(a) Samples with two serotypes tested with PCR 1
49 1:1, 3:19F 16,318 16,318 77.8 22.1 0 NA NA NA
50 1:10, 19F:3 17,473 17,473 80.8 18.9 0.1 NA NA NA
51 1:10, 3:19F 19,239 19,239 85.0 14.8 0 NA NA NA
52 1:50, 19F:3 11,986 11,986 80.2 19.6 0 NA NA NA
53 1:50, 3:19F 4,853 4,853 82.3 17.5 0.1 NA NA NA
54 1:100, 19F:3 7,447 7,447 77.4 22.2 0.1 NA NA NA
55 1:100, 3:19F 4,251 4,251 85.5 13.7 0.2 NA NA NA
(b) Samples with two serotypes tested with PCR 2
56 1:1, 3:19F 9,700 6,631 76.2 22.8 1.0 3,069 99.7 0.3
57 1:10, 19F:3 17,282 12,952 79.8 19.9 0.2 4,330 99.7 0.3
58 1:10, 3:19F 10,644 7,690 84.1 15.8 0.2 2,954 99.7 0.3
59 1:50, 19F:3 11,623 8,666 79.2 20.7 0.2 2,957 99.6 0.4
60 1:50, 3:19F 6,378 4,392 85.2 14.6 0.3 1,986 99.4 0.6
61 1:100, 19F:3 8,673 6,385 79.9 19.8 0.3 2,288 99.4 0.6
62 1:100, 3:19F 5,740 4,023 85.8 13.9 0.4 1,717 99.0 1.0
(c) Samples with proportionately mixed Streptococcus pneumoniae and NCTC 11189 Streptococcus sp. viridans type. tested with PCR 2
63 1:1, NCTC 11189:19F 10,408 7,621 99.9 NA 0 2,787 46.6 53.4
64 1:10, 19F:NCTC 11189 3,459 2,112 99.9 NA 0.1 1,347 32.5 67.5
65 1:10, NCTC11189:19F 1,252 842 97.7 NA 1.8 410 86.1 13.9
66 1:50, 19F:NCTC 11189 18,079 10,467 100 NA 0 7,612 10.2 89.8
67 1:50, NCTC 11189:19F 16,336 10,172 99.8 NA 0 6,164 81.4 18.6
68 1:100,19F:NCTC 11189 18,259 8,612 100 NA 0 9,647 7.6 92.4
69 1:100, NCTC 11189:19F 8,694 3,559 100 NA 0 5,135 64.4 35.6
*Denominator – total number of reads mapped against serotype/group specific sequences.
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http://www.biomedcentral.com/1471-2180/14/60methods for target enrichment is not widely available for
microbiological applications and the kits remain expen-
sive. However, the availability of Taq polymerases with
increased multiplexing capabilities and the elimination
of the necessity for the gel-based differentiation of bands
increase the possibility of using multiplex PCR for target
enrichment. In addition to using this method for typing
organisms, syndrome-based identification panels could
also be developed by using a similar methodology.
Conclusions
We demonstrated the feasibility of using a custom
enrichment-based sequencing methodology for S. pneu-
moniae identification and serotyping. A multiplex PCR
containing primers for serotype/group specific regions of
the 23 valent polysaccharide vaccine serotypes was used
for target enrichment followed by NGS on a Miseq plat-
form to serotype pneumococci successfully at cut-off
read levels defined during the study. A second multiplex
PCR containing an additional pair of primers that help
to identify pneumococci was also successfully applied for
target enrichment. The first enrichment PCR could be
used to serotype identified pneumococcal isolates while
the latter one could be used on primary cultures and dir-
ect samples. The principle of using simple multiplex
PCR for target enrichment followed by NGS could be
adapted for syndrome-based diagnosis and typing using
either bacterial isolates or patient samples.
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